JP2009001575A5 - - Google Patents

Download PDF

Info

Publication number
JP2009001575A5
JP2009001575A5 JP2008163588A JP2008163588A JP2009001575A5 JP 2009001575 A5 JP2009001575 A5 JP 2009001575A5 JP 2008163588 A JP2008163588 A JP 2008163588A JP 2008163588 A JP2008163588 A JP 2008163588A JP 2009001575 A5 JP2009001575 A5 JP 2009001575A5
Authority
JP
Japan
Prior art keywords
ozone
ppm
mucous membrane
external preparation
initial concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008163588A
Other languages
Japanese (ja)
Other versions
JP2009001575A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2008163588A priority Critical patent/JP2009001575A/en
Priority claimed from JP2008163588A external-priority patent/JP2009001575A/en
Publication of JP2009001575A publication Critical patent/JP2009001575A/en
Publication of JP2009001575A5 publication Critical patent/JP2009001575A5/ja
Pending legal-status Critical Current

Links

Claims (1)

オゾン溶存グリセリン溶液を含む、無傷の皮膚または粘膜に用いられる外用剤であって、オゾンの濃度の初期値が少なくとも８５ｐｐｍである、前記外用剤。   An external preparation for use on intact skin or mucous membrane, comprising an ozone-dissolved glycerin solution, wherein the initial concentration of ozone is at least 85 ppm.
JP2008163588A 2008-06-23 2008-06-23 Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical) Pending JP2009001575A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008163588A JP2009001575A (en) 2008-06-23 2008-06-23 Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008163588A JP2009001575A (en) 2008-06-23 2008-06-23 Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006166364A Division JP2007332078A (en) 2006-06-15 2006-06-15 Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)

Publications (2)

Publication Number Publication Date
JP2009001575A JP2009001575A (en) 2009-01-08
JP2009001575A5 true JP2009001575A5 (en) 2009-07-30

Family

ID=40318354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008163588A Pending JP2009001575A (en) 2008-06-23 2008-06-23 Agent for external use containing ozone-dissolved glycerol solution such as cosmetic, quasi-drug or medicament (pharmaceutical)

Country Status (1)

Country Link
JP (1) JP2009001575A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101244112B1 (en) * 2011-07-21 2013-03-18 주식회사 탑 엔지니어링 Method of manufacturing the optical absorber layer for solar cell, Solar cell including the optical absorber layer and Method of manufacturing the same
KR101514343B1 (en) * 2013-12-23 2015-04-22 참좋은우리 주식회사 How to make ozonated olive oil with raventer essential oil
CN104644467B (en) * 2015-02-12 2016-01-20 安婕妤化妆品科技股份有限公司 A kind of cosmetics containing fullerene derivate
ITUB20156870A1 (en) * 2015-12-11 2017-06-11 Laboratori Baldacci Spa Synergistic combination of pyrrolidone carboxylic acid and / or its salts or derivatives and hyaluronic acid and / or its salts, for use in the treatment and / or prevention of dryness and irritation of the mucous membranes, and relative pharmaceutical formulations.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2271395T3 (en) * 2002-02-23 2007-04-16 Hwajin Cosmetics Co., Ltd. TOTAL SKIN TREATMENT SYSTEM AND PROCEDURE USING THE SAME.
JP4677192B2 (en) * 2004-02-20 2011-04-27 株式会社オゾテック Method for producing ozone-dissolved glycerin solution

Similar Documents

Publication Publication Date Title
LTPA2020006I1 (en) GDF traps for use in the treatment of anemia
UY31765A (en) SUBSTITUTED DIHYDROPIRAZOLONAS AND ITS USE
CO6440531A2 (en) 2-ACETAMIDO-5-ARIL-1,2,4-SUBSTITUTED TRIAZOLONES AND ITS USE
BRPI0917006A2 (en) prolonged drug release agent, adsorbent, food, mask having an adsorbent, and adsorption sheet
WO2011061330A3 (en) Use of physiological cooling active ingredients, and agents containing such active ingredients
CL2008001994A1 (en) COMPOUNDS DERIVED FROM PIRAZIN-2-ONA; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, ATEROSCLEROSIS, HYPERTENSION, AMONG OTHERS.
ZA201101638B (en) Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
JP2010525055A5 (en)
WO2010036395A3 (en) Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
BR112013004846A2 (en) "Antimicrobial Membrane, Filter, Water Purification Device and Process for Making an Antimicrobial Membrane".
CL2008000461A1 (en) USE OF ACLIDINIO IN THE TREATMENT OR PREVENTION OF A DISEASE OR A RESPIRATORY STATE IN A PATIENT BY INHALATION, WITHOUT PRODUCING IN THIS PATIENT SYSTEMIC ANTIMUSCARINIC EFFECTS.
IT1395519B1 (en) COMPOSITE PIECE, AS WELL AS THE USE OF THE COMPOSITE PIECE
JP2008542528A5 (en)
WO2008148573A3 (en) Medicament comprising an active substance combination containing pantothenic acid or the derivatives thereof for the treatment of allergy symptoms
JP2012516348A5 (en)
BRPI0818121A2 (en) diespiro 1,2,4-trioxolane and its methods of manufacture and use
CL2007002769A1 (en) COMPOUNDS DERIVED FROM SULFONAMIDE; OBTAINING PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DIABETES.
JP2009001575A5 (en)
ATE531715T1 (en) 1,3-DIHYDRO-2H-PYRROLOÄ3.2-BÜPYRIDINE-2-ONDERIVA E, THEIR PRODUCTION AND THEIR THERAPEUTIC USES
BRPI0817483A2 (en) use of sulfonyl substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain
JP2014054318A5 (en)
WO2009074498A8 (en) Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
JP2009292763A5 (en)
BRPI0821432A2 (en) 15,16-Methylene-17-hydroxy-19-nor-21-carboxylic acid steroid gamma-lactone derivative, its use and medicaments containing the derivative.
CL2013001596A1 (en) Process of purification and stabilization of the enzyme gluconate dehydrogenase (gadh, ec 1.1.99.3); gluconate dehydrogenase enzyme (gadh, ec 1.1.99.3); and use of the enzyme gluconate dehydrogenase (gadh, ec 1.1.99.3).